MSB 2.29% $1.12 mesoblast limited

Athersys’, Pluristem’s and Mesoblast’s mesenchymal stromal cell therapies vie for efficacy in Covid-19, page-70

  1. 1,174 Posts.
    lightbulb Created with Sketch. 22
    and me too, celestial. I have not read his posts for years because of the incessant crap - nothing to do with the substance of the company, just peripheral expressions of nothingness.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.